LC-MS/MS Based Quantitative Analysis of Remogliflozin in Rat Plasma: A Kinetic Study Approach
Keywords:
Remogliflozin, Rat Plasma, UPLC-MS/MS, Isocratic Elution, BixafenAbstract
This research utilized high-performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS) method to quantitatively measure concentration of remogliflozin in rat plasma using bixafen as the internal standard. Samples were prepared by aqueous acetonitrile-based protein precipitation technique. Remogliflozin was then analysed by isocratic elution chromatography with a mobile phase consisting of 0.1% formic acid in milli-Q water (20): acetonitrile (80). Remogliflozin was monitored by m/z 451.4→289.4 transition for quantification and m/z 451.4→111.2 transition for qualification, and bixafen was determined by m/z 414.0→ 394 by multiple reaction monitoring (MRM) in positive ion electrospray ionization (ESI) source. Method exhibited good linearity in the range of 15 ng/mL to 2009 ng/mL. During pharmacokinetic experiments involving oral administration of remogliflozin in rat, the time to reach maximum concentration (Tmax) was found to 0.5 h in both males and females. The maximum concentration (Cmax) was found to be 201 ng/mL in males and 293 ng/mL in females while the last area under the concentration-time curve (AUClast) was determined to be 448 ng*h/mL for males and 297 ng*h/mL for females.
Downloads
References
M.R. Tammisetty, B.R. Challa, S.B. Puttagunta, Turkish Journal of Pharmaceutical Sciences, 18(3) (2021), doi: 10.4274/tjps.galenos.2020.39699
American Diabetes Association Professional Practice Committee; 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes 2024. Diabetes Care, 2024; 47 (Supplement-1): S158–S178, doi: https://doi.org/10.2337/dc24-S009
M.A Abdul-Ghani, L. Norton, R.A DeFronzo, American Journal of Physiology Renal Physiology, 309(11) (2015), doi:10.1152/ajprenal.00267.2015
R. Maccari, R. Ottanà, Journal of Medicinal Chemistry, 65(16) (2022), doi:10.1021/acs.jmedchem.2c00867
T. Madaan, M. Akhtar, A.K Najmi, European Journal of Pharmaceutical Sciences, 93, (2016), doi:10.1016/j.ejps.2016.08.025
A. Markham, Drugs, 79(10) (2019), doi:10.1007/s40265-019-01150-9
M. Tandrima, K.S. Gubbiyappa, Rasayan Journal of Chemistry, 16(2) (2023), doi: http://doi.org/10.31788/RJC.2023.1628240
E. D. L. Putra, N. Nazliniwaty, F. R. Harun, N. Nerdy, Rasayan Journal of Chemistry, 13(2), 968(2020), http://dx.doi.org/10.31788/RJC.2020.1325645
I. Sopyan, D. Dwiputri, M. Muchtarid, Rasayan Journal of Chemistry, 13(4) (2020), http://dx.doi.org/10.31788/RJC.2020.1346045
K. Chandrasekhar, A. Manikandan, Rasayan Journal of Chemistry, 14(2) (2021), http://dx.doi.org/10.31788/RJC.2021.1425740
S.J. Patel , B. Chauhan, B. Shaikh, P. Chavan, N. Khan, Research Journal of Pharmacy and Technology, 17(10) (2024), doi: 10.52711/0974-360X.2024.0077
U. Jisha, S.S Prasanth, M.K Sibina, P.K. Sanooja, K.T. Akshara, R. Rajan, M. Farooq, A. A. Ajay, International Journal of pharmaceutical sciences, 2(8) (2024) doi: https://doi.org/10.5281/zenodo.13376811
V.H Herck, V. Baumans, C.J. Brandt, H.A Boere, A.P Hesp, H.A van Lith, M. Schurink, A.C Beynen, Laboratory Animals, 35(2) (2001), doi: 10.1258/0023677011911499
https://www.fda.gov/files/drugs/published/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
Terms:
- Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
